|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.34 | 89.43 | 104.26 | 0.53 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pharmaceuticals & Drugs
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
314.65
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
|
( Rs. in Million)
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Profit Before Tax | 29,712.00 | 1,397.00 | 3,588.00 | 5,599.00 | 5,521.00 | Adjustment | -27,269.00 | 1,083.00 | 1,178.00 | -681.00 | -1,118.00 | Changes In working Capital | 161.00 | -1,720.00 | 1,560.00 | -140.00 | -1,939.00 | Cash Flow after changes in Working Capital | 2,604.00 | 760.00 | 6,326.00 | 4,778.00 | 2,464.00 | Cash Flow from Operating Activities | 2,193.00 | 476.00 | 5,713.00 | 3,871.00 | 1,095.00 | Cash Flow from Investing Activities | -11,778.00 | -3,056.00 | -7,112.00 | -2,129.00 | 3,109.00 | Cash Flow from Financing Activities | 10,394.00 | 1,120.00 | 278.00 | -1,289.00 | -2,082.00 | Net Cash Inflow / Outflow | 809.00 | -1,460.00 | -1,121.00 | 453.00 | 2,122.00 | Opening Cash & Cash Equivalents | 1,110.00 | 2,535.00 | 3,750.00 | 3,057.00 | 891.00 | Cash & Cash Equivalent on Amalgamation / Take over / Merger | 0 | 0 | 0 | 0 | 0 | Cash & Cash Equivalent of Subsidiaries under liquidations | 0 | 0 | 0 | 0 | 0 | Translation adjustment on reserves / op cash balalces frgn subsidiaries | 0 | 0 | 0 | 0 | 0 | Effect of Foreign Exchange Fluctuations | 47.00 | 35.00 | -94.00 | 240.00 | 44.00 | Closing Cash & Cash Equivalent | 1,966.00 | 1,110.00 | 2,535.00 | 3,750.00 | 3,057.00 |
|
|
|
|
|
|